PrimeRFP SCOUT · Federal Contract Recompete Brief

SPE2DX21FZ8WS4554629206!xolair 150 MG ML syringeml — Dms Pharmaceutical Group Inc

Dms Pharmaceutical Group Inc holds $737.3M across 100,503 federal awards, concentrated at Department of Defense (DOD). This PIID sits alongside 1 related award in the incumbent pipeline.

Dla Troop Support
Awarding office
Dms Pharmaceutical Group Inc
Recipient
—
Estimated value
6505
PSC

Watch this recompete

One email. No account. We ping you if the window moves.

Contract facts

Federal
Contract numberSPE2DX21FZ8WS
AgencyDla Troop Support
Awarding officeDla Troop Support
Awarding agencyDepartment of Defense (DOD)
Funding agencyDepartment of Defense (DOD)
IncumbentDms Pharmaceutical Group Inc
UEIPX72BSBQTKJ3
PSC6505

4554629206!XOLAIR 150 MG/ML SYRINGEML is a federal award for Dla Troop Support held by Dms Pharmaceutical Group Inc. Estimated value —.

Bonuses end Sept 30

Want the durability read on SPE2DX21FZ8WS? One Pursuit Analysis, $500, inside 48 business hours.

  • 48 business hours
  • $500
  • Credits toward the Pack
Buy one Pursuit Analysis — $500

Incumbent footprint

Public record

Dms Pharmaceutical Group Inc — $737.3M obligated across 100,503 awards (firm-wide, all agencies) · lead buyer Department of Defense (DOD).

% of firm-wide obligated ($737.3M) · all agencies
Department of Defense (DOD)$737.1M · 100%Department of Veterans Affairs (VA)$193K · 0%
Open full company profile →

Related awards

Same incumbent
SPE2D026F0120
8511978882!OTHER MEDICAL
$248K
Apr 26, 2027

Query this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →

More in SCOUT
Size up the competition →Research the incumbent →

Frequently asked questions

What is contract SPE2DX21FZ8WS?

SPE2DX21FZ8WS (4554629206!xolair 150 MG ML syringeml) is a Dla Troop Support award with an estimated value of —, currently held by Dms Pharmaceutical Group Inc. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.

Which office awarded SPE2DX21FZ8WS?

Dla Troop Support awarded SPE2DX21FZ8WS to Dms Pharmaceutical Group Inc.

Who is the incumbent on SPE2DX21FZ8WS?

Dms Pharmaceutical Group Inc is the incumbent with $737.3M across 100503 related awards in SCOUT’s public footprint.

When does Dms Pharmaceutical Group Inc’s SPE2DX21FZ8WS come up for recompete?

SCOUT tracks a period-of-performance end of an unstated date. Actual solicitation timing can shift with extensions, bridges, or consolidations.

Want the durability read on SPE2DX21FZ8WS? One Pursuit Analysis, $500, inside 48 business hours.

One Pursuit Analysis is $500 and credits toward the Sprint Pack. Delivery is 48 business hours. Start with the free Exposure Check if you want the list first.

Get the free Exposure Check

No card · under a minute · then the Sprint menu

Buy one Pursuit Analysis — $500

Credits toward the Sprint Pack

Compare plans

Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.

Data as of · refreshed monthly
Sources: USASpending, FPDS, SAM.gov · Public-record facts + SCOUT analysis shown above; personalized scoring in SCOUT.
primerfp.com/intel/contract/SPE2DX21FZ8WS